Safety of Omegaven in Pediatric Patients With Parenteral Nutrition-Associated Cholestasis (PNAC)
Conditions: Parenteral Nutrition Associated Liver Disease; Essential Fatty Acid Deficiency; Neurocognitive Deficit; Malnutrition; Pediatric ALL Intervention: Drug: Omegaven® (fish oil triglycerides) Injectable Emulsion Sponsor: Fresenius Kabi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2021 Category: Research Source Type: clinical trials
Probiotics in Pediatric Chronic Cholestasis
Condition: Cholestatic Liver Disease Interventions: Other: placebo; Combination Product: probiotics Sponsor: Indonesia University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2021 Category: Research Source Type: clinical trials